Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 4 1Phase 3 1Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 13Breast Neoplasms 9Prostatic Neoplasms 4Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Pain, Postoperative 3Ovarian Neoplasms 3Neoplasm Metastasis 3Fallopian Tube Neoplasms 3Stomach Neoplasms 2Pancreatic Neoplasms 2Lymphoma 2Hemorrhage 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thromboembolism 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Peritoneal Neoplasms 1Peripheral Nervous System Diseases 1Pancreatic Cyst 1Pain 1Non-Muscle Invasive Bladder Neoplasms 1Neurotoxicity Syndromes 1Myofibroma 1Multiple Myeloma 1Metabolic Diseases 1Melanoma 1

Interventions

Fluorouracil 72Leucovorin 71Oxaliplatin 47Irinotecan 31Capecitabine 24Bevacizumab 23Folfox protocol 20Cetuximab 15Chemotherapy, Adjuvant 13Celecoxib 7Aspirin 6Laparoscopy 5XELOX 4Panitumumab 4Neoadjuvant Therapy 4Levamisole 4dehydroftorafur 3Tegafur 3Surgical Procedures, Operative 3Observation 3Floxuridine 3vatalanib 2tislelizumab 2pertuzumab 2encorafenib 2atezolizumab 2Trastuzumab 2Standard of Care 2Semaxinib 2Selenium 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Colonic Neoplasms × Saline Solution × Clear all
NCT06910514 2025-04-09

Efficacy and Safety of a Solution for Endoscopic Mucosal Resection of Colonic Lesions

Nakafarma S.L.

Phase 3 Completed
52 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡